Results 131 to 140 of about 14,446 (149)

Effect of Rare-Earth Co-Doping on the Trap Level Concentrations in Silica Glasses: Experimental and Theoretical Study of the Light Emission Under X-Rays for Dosimetry Applications. [PDF]

Sensors (Basel)
Zghari I, El Hamzaoui H, Morana A, Ouerdane Y, Capoen B, Garzandat S, Girard S, Boukenter A, Mady F, Benabdesselam M, Mélin G, Bouazaoui M.   +11 more
europepmc   +1 more source

Case Report: Response to ivosidenib in patients with cholangiocarcinoma: a clinical perspective with illustrative cases. [PDF]

Front Oncol
Buccella Y.
europepmc   +1 more source

Primary Care Providers' Perspectives of Knowledge and Skill Acquisition, and Benefits Following University Faculty-Led Continuing Medical Education Sessions: Results of a Qualitative Assessment in Southwest Uganda. [PDF]

Cureus
Mulogo E, Ntaro M, Turyakira E, Matte M, Wesuta A, Mwebembezi F, Agaba F, Nabimanya P, Tushabe A, Kawungezi P.   +9 more
europepmc   +1 more source

The evolving landscape of first-line and subsequent therapies in <i>EGFR</i>-mutated NSCLC: efficacy, resistance, and tolerability. [PDF]

Explor Target Antitumor Ther
Della Corte CM, De Rosa C, Ul Haq F, Morgillo F.   +3 more
europepmc   +1 more source

Disrupting the TGF-β-regulated epithelial-mesenchymal transition, apoptotic and autophagic phenotypes of 3D glioblastoma spheroids via glycolytic inhibition. [PDF]

Explor Target Antitumor Ther
Payet-Desruisseaux M, Zgheib A, Danalache BA, Desjarlais M, Annabi B.   +4 more
europepmc   +1 more source

Nodule ombilical tumoral comme signe d’appel d’une tumeur de Krukenberg sous-jacente. [PDF]

CMAJ
Chen TL, Ho YH.
europepmc   +1 more source

Above and beyond the Lab ScaleCreating a kW-Sized AEM Electrolyzer Validated by In-Situ Distribution of Relaxation Times. [PDF]

Energy Fuels
Nuggehalli Sampathkumar S, Benjamin Ferriday T, Mury Z, Aubin P, Lawand K, Van Herle J.   +5 more
europepmc   +1 more source

Mortality impact of an increased blood glucose cut-off level for hypoglycaemia treatment in severely sick children aged 5 to 12 years in Malawi - an exploratory randomised controlled study. [PDF]

BMC Pediatr
Ngwalangwa F, Nyaika M, Baker T, Dube Q, Langton J, Hildenwall H.   +5 more
europepmc   +1 more source

Réaction cutanée provoquée par l’enfortumab védotine. [PDF]

CMAJ
Gretschel L, Wetzel E, Mittank-Weidner T.   +2 more
europepmc   +1 more source